Alliant Pharmaceuticals has acquired rights to two drugs and also secured private funding for the building of a sales infrastructure.

The amount of the private placement was not disclosed. Making the investment is EJ Financial of Lake Forest, IL. The money will be used to “build the company’s sales infrastructure,” Alliant said.

The drugs were licensed from Mallinckrodt. Both are used to treat attention deficit hyperactive disorder.

Alliant focuses on pediatric pharmaceuticals.